5 completed, 2 unknown. 2 Early Phase 1, 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 2 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow alpha-Galactosidase: new trials by email Literature Review of alpha-Galactosidase trials Research Report on alpha-Galactosidase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glycemic Response of Whole Beans and Bean Products Alpha galactosidase, Placebo - Healthy, Body Mass Index, Normal | Early Phase 1 | Completed | Iowa State University | 21 | 2023-03-28 | 2024-10-08 |
| A Study to Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy. Enzyme Replacement Therapy (ERT) - Fabry Disease | Completed | Amicus Therapeutics | 82 | 2020-03-01 | 2026-02-05 | |
| Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease Enzyme replacement therapy (Agalsidase alpha (Replagal®)), Magnetic Resonance Imaging - Anderson-Fabry Disease | Not applicable | Completed | University Hospital, Rouen | 26 | 2017-03-25 | 2026-04-17 |
| Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients GLA gene - Fabry Disease | Unknown | Chiayi Christian Hospital | 1000 | 2016-01-01 | 2018-07-23 | |
| The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in Irritable Bowel Syndrome (IBS) Alpha-Galactosidase - Irritable Bowel Syndrome | Early Phase 1 | Completed | Sahlgrenska University Hospital | 20 | 2011-11-01 | 2014-11-18 |
| Alpha-galactosidase Enzyme and Irritable Bowel Syndrome Alpha-galactosidase - Irritable Bowel Syndrome | Not applicable | Unknown | Verman Oy Ab | 150 | 2010-12-01 | 2011-01-17 |
| Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease Replagal - Fabry Disease | Phase 3 | Completed | Shire | 35 | 2010-04-13 | 2021-06-08 |
Fabry Disease (4) · Irritable Bowel Syndrome (2) · Dilatation, Pathologic (1) · Hyperglycemia (1) · Insulin Resistance (1)
Amicus Therapeutics (1) · Chiayi Christian Hospital (1) · Iowa State University (1) · Sahlgrenska University Hospital (1) · Shire (1) · University Hospital, Rouen (1) · Verman Oy Ab (1)
United States (3) · Finland (2) · Australia (1) · Brazil (1) · Czechia (1) · France (1) · Japan (1) · Poland (1) · Slovenia (1) · Sweden (1) · Taiwan (1) · Turkey (Türkiye) (1) · United Kingdom (1)
PMID 26185417, PMID 39988522, PMID 40790487
2009 (1)